WaveMan · Form 4
Khattar Jack A. insider trades
> Search tickers & screens ⌘K
LIVE

Khattar Jack A. insider trades

Khattar Jack A. has filed 80 Form 4s with the SEC that we hold, for Supernus Pharmaceuticals, INC. (SUPN) (President, CEO, Director), Cognition Therapeutics INC (CGTX) (Director) and SCPH (Director). Across all of them we count 1 purchase worth $19.6K and 41 sales worth $39.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($1.8M). The largest single trade was a sale of 125,000 shares of Supernus Pharmaceuticals, INC. worth $4.6M, dated 2024-11-07. The first filing on our record is dated 2021-07-30 and the latest 2026-08-14.

Supernus Pharmaceuticals, INC. (SUPN)

President, CEO, Director · 68 filings · 41 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-08-08S, sale reported on Form 410,032$322.1K2022-08-09
2022-08-08S, sale reported on Form 4107,875$3.4M2022-08-09
2022-08-09S, sale reported on Form 439,431$1.2M2022-08-10
2022-08-10S, sale reported on Form 428,437$887.8K2022-08-11
2022-08-15S, sale reported on Form 417,302$588.8K2022-08-17
2022-08-16S, sale reported on Form 414,690$499.6K2022-08-18
2022-11-15S, sale reported on Form 41,115$39.0K2022-11-17
2022-11-21S, sale reported on Form 4531$18.6K2022-11-22
2022-11-22S, sale reported on Form 4600$21.0K2022-11-23
2022-11-23S, sale reported on Form 42,259$79.2K2022-11-28
2022-11-25S, sale reported on Form 411,135$391.7K2022-11-28
2022-12-20S, sale reported on Form 44,006$152.3K2022-12-22
2022-12-21S, sale reported on Form 411,354$433.0K2022-12-22
2023-01-17S, sale reported on Form 425,446$1.0M2023-01-19
2023-01-18S, sale reported on Form 44,936$199.4K2023-01-20
2023-01-31S, sale reported on Form 4976$41.0K2023-02-02
2023-02-01S, sale reported on Form 4300$12.6K2023-02-03
2023-02-02S, sale reported on Form 413,532$569.2K2023-02-06
2023-02-03S, sale reported on Form 4200$8.4K2023-02-06
2024-11-07S, sale reported on Form 4125,000$4.6M2024-11-08
2024-11-08S, sale reported on Form 4125,000$4.5M2024-11-12
2025-08-06S, sale reported on Form 463,500$2.7M2025-08-08
2025-08-06S, sale reported on Form 438,000$1.6M2025-08-08
2025-08-06S, sale reported on Form 438,500$1.5M2025-08-08
2025-08-22S, sale reported on Form 41,500$67.5K2025-08-26
2025-08-25S, sale reported on Form 41,000$45.0K2025-08-27
2025-08-27S, sale reported on Form 410,650$479.8K2025-08-29
2025-08-28S, sale reported on Form 424,150$1.1M2025-08-29
2025-09-05S, sale reported on Form 455,578$2.6M2025-09-08
2025-09-08S, sale reported on Form 46,322$292.6K2025-09-09
2025-09-22S, sale reported on Form 416,587$779.9K2025-09-23
2025-09-23S, sale reported on Form 429,513$1.4M2025-09-24
2025-09-29S, sale reported on Form 410,235$491.5K2025-09-30
2025-09-30S, sale reported on Form 48,588$414.4K2025-10-01
2025-10-01S, sale reported on Form 440,173$1.9M2025-10-02
2025-10-02S, sale reported on Form 41,904$91.5K2025-10-03
2025-10-09S, sale reported on Form 458,371$3.0M2025-10-10
2025-10-09S, sale reported on Form 41,529$78.7K2025-10-10
2026-03-13S, sale reported on Form 4120$6.2K2026-03-16
2026-03-13S, sale reported on Form 410,742$547.8K2026-03-16
2026-03-13S, sale reported on Form 424,138$1.2M2026-03-16

Cognition Therapeutics INC (CGTX)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

SCPH

Director · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-12-03P, purchase reported on Form 45,000$19.6K2021-12-06
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1539937) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms